(Sawbridgeworth, UK, October 24 2011) Exco InTouch, the leading provider of patient communication solutions for the pharmaceutical and healthcare sectors, today announced that it is a winner of the 2011 Deloitte Technology Fast 50. The awards, now in their 14th year, are an independent ranking of the 50 fastest growing technology companies in the UK, based on percentage growth in revenue over five years. Exco InTouch was placed as the 44th fastest growing company in the country and the 7th fastest growing company in the South East region. Receipt of the Fast 50 award is a significant achievement, recognising growth based on innovation and entrepreneurship. Exco InTouch’s win comes on the back of a recent growth investment from leading growth equity and venture capital group Scottish Equity Partners (SEP).
Exco InTouch, whose clients include nine of the world’s top 10 pharmaceutical businesses, offers an innovative suite of patient-focused services which are delivered using a combination of cell-phone and internet technology. Used in clinical trials, the company’s services benefit both patients and pharmaceutical clients, providing patient recruitment and retention support. These unique services result in improved overall compliance and the facilitation of the electronic capture of patient reported outcomes data (ePRO) during clinical trials and in Late Phase observational studies. The business, which employs some 40 staff, has its headquarters in the UK and offices in the United States and recently opened a second UK office in Nottingham to accommodate up to 30 more staff.
With the recent £3m investment from SEP, Exco InTouch is entering its next growth phase, enabling it to invest further in people, technology and infrastructure and to further enhance its revolutionary mobile technology platform. SEP has taken a minority stake in the company. Exco InTouch will use the funds to take advantage of significant growth opportunities in the clinical trial sector, particularly in the emerging mobile patient communication market. Demand for its services is growing exponentially as pharmaceutical companies are increasingly adopting smart technology to optimise clinical trial execution.
“Making the Deloitte Technology Fast 50 is a testament to a company’s commitment to technology”, says Mark Doleman, Regional Partner, Deloitte UK Technology Fast 50 and Technology Fast 500 EMEA Programmes. “With its 730% growth rate over five years, Exco InTouch has proven that its leadership has the vision and determination to grow in competitive conditions.”
“The Deloitte UK Technology Fast 50 is internationally recognised as being one of the most important business awards in the sector and we are thrilled to receive this accreditation”, comments Tim Davis, CEO of Exco InTouch. “Despite economic uncertainty, the past five years have proved highly successful for us, with particular growth in our ePRO and patient engagement services. We look forward to this continued growth in the future as sponsors increasingly recognise the benefits of our mobile technology in the healthcare and drug development sectors.”
For further information on the Exco InTouch range of solutions, please call +44 1279 709 040 or +1 877 327 5777 or visit www.excointouch.com.
For further press information please contact: Fiona Robinson, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA Tel: +44 1477 539539 Fax: +44 1477 539540 e-mail: exco@scottpr.com
About Exco InTouch:
Exco InTouch is the leading provider of regulatory compliant interactive mobile patient communication solutions for Patient Recruitment, Retention, Compliance, ePRO/eDiary and Late Phase studies. Using a combination of software and services, Exco InTouch solutions provide simple, quick and non-intrusive channels of communication that enables sponsors, CROs, sites and patient recruitment agencies, find the right patients; keep them in their studies; motivate them to maintain full compliance and facilitate the collection of quality patient data, thus ensuring a better overall patient experience.
These solutions are currently being used by hundreds of thousands of patients in over 70 countries, delivered in the local language and are fully compliant with HIPAA regulations, FDA CFR 21 Part 11 and all electronic communication privacy directives.
About Deloitte:
In this press release references to Deloitte are references to Deloitte LLP, which is among the country's leading professional services firms.
Deloitte LLP is the United Kingdom member firm of Deloitte Touche Tohmatsu (‘DTT’), a Swiss Verein, whose member firms are legally separate and independent entities. Please see www.deloitte.co.uk/about for a detailed description of the legal structure of DTT and its member firms.
The information contained in this press release is correct at the time of going to press.
For more information, please visit www.deloitte.co.uk.
Deloitte Technology, Media & Telecommunications (TMT) Group
The Deloitte TMT Group is composed of service professionals who have a wealth of experience serving technology, media and telecommunications companies throughout the UK in areas including cable, communications providers, computers and peripherals, entertainment, media and publishing, networking, semiconductors, software, wireless, and related industries. These specialists understand the challenges that these companies face throughout all stages of their business growth cycle and are committed to helping them succeed. Deloitte is a leader in providing strategic, financial and operational assistance to its technology, media and telecommunications clients.
For more information, please visit www.deloitte.co.uk/tmt
No comments:
Post a Comment